Stockholm III trial

Denna sida på svenska

The Stockholm III trial is a randomised, multicentre trial, comparing different radiationtherapy courses in primary resectable rectal cancer.

Patients are randomised between one of the following arms:

  1. Preoperative radiotherapy 5 x 5 Gy with surgery within one week
  2. Preoperative radiotherapy 5 x 5 Gy with surgery after 4-8 weeks
  3. Preoperative radiotherapy 25 x 2 Gy with surgery after 4-8 weeks

Inclusion criteria:

Primary resectable, biopsy proven adenocarcinoma of the rectum, without signs of distant metastases where abominal surgery is planned. 

Primary Investigator

Professor/senior physician

Anna Martling

Phone: +46-(0)8-517 728 02
Organizational unit: Colorectal Surgery
E-mail: Anna.Martling@ki.se

www.clinicaltrials.gov NCT00904813

Study protocol

Study protocol Stockholm III

Cancer and Oncology